These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 6766650)

  • 1. Long-term therapy of heart failure with prazosin: a randomized double blind trial.
    Colucci WS; Wynne J; Holman BL; Braunwald E
    Am J Cardiol; 1980 Feb; 45(2):337-44. PubMed ID: 6766650
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of prazosin vs placebo on chronic left ventricular heart failure.
    Aronow WS; Lurie M; Turbow M; Whittaker K; Van Camp S; Hughes D
    Circulation; 1979 Feb; 59(2):344-50. PubMed ID: 365391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of prazosin in the management of chronic congestive heart failure: a 6-month randomized, double-blind, placebo-controlled study.
    Markham RV; Corbett JR; Gilmore A; Pettinger WA; Firth BG
    Am J Cardiol; 1983 May; 51(8):1346-52. PubMed ID: 6342353
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of trimazosin and prazosin therapy on cardiac and exercise performance in outpatients with chronic congestive heart failure.
    Aronow WS; Danahy DT
    Am J Med; 1978 Jul; 65(1):155-60. PubMed ID: 356598
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Lack of symptomatic and long-term hemodynamic effects of prazosin in chronic heart failure. Double-blind, randomized study over one year].
    Reifart N; Schmidt-Moritz AD; Nadj M; Kaltenbach M; Bussmann WD
    Z Kardiol; 1985 Apr; 74(4):205-12. PubMed ID: 3923726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term ambulatory therapy with prazosin versus placebo for chronic heart failure: relation between clinical response and left ventricular function at rest and during exercise.
    Higginbotham MB; Morris KG; Bramlet DA; Coleman RE; Cobb FR
    Am J Cardiol; 1983 Oct; 52(7):782-8. PubMed ID: 6353898
    [No Abstract]   [Full Text] [Related]  

  • 7. Role of the renin-angiotensin system in the development of hemodynamic and clinical tolerance to long-term prazosin therapy in patients with severe chronic heart failure.
    Packer M; Medina N; Yushak M
    J Am Coll Cardiol; 1986 Mar; 7(3):671-80. PubMed ID: 2869077
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Long-term treatment of cardiac insufficiency with prazosin].
    Grolleau R; Errera J; Gallay P
    Ann Cardiol Angeiol (Paris); 1984; 33(4):247-51. PubMed ID: 6465817
    [No Abstract]   [Full Text] [Related]  

  • 9. Increase in plasma norepinephrine during prazosin therapy for chronic congestive heart failure.
    Stein L; Henry DP; Weinberger MH
    Am J Med; 1981 Apr; 70(4):825-32. PubMed ID: 7011023
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Comparative study between prazosin and methyldopa in essential arterial hypertension: results of a parallel, randomized double-blind trial].
    Whelton PK; Russell R; Sova-Schultz K; Wyndham R; Walker WG
    Cardiology; 1980; 66 Suppl 2():59-67. PubMed ID: 7026032
    [No Abstract]   [Full Text] [Related]  

  • 11. [Prazosin in arterial hypertension with cardiac insufficiency].
    Antani JA
    Cardiology; 1980; 66 Suppl 2():132-7. PubMed ID: 6456812
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of prazosin on plasma renin activity and blood pressure.
    Karlberg BE; Thulin T; Fagerberg SE; Schersten B; Tolagen K; Vikesdal O; Malmberg L
    J Clin Pharmacol; 1979 Jul; 19(7):357-65. PubMed ID: 479380
    [No Abstract]   [Full Text] [Related]  

  • 13. [Evaluation of prazosin in heart failure using exercise tests: short- and long-term results].
    Sánchez Domínguez J; Barciela Vilas R; Largo Aguado F; Urbina Fuentes FJ; González Villa J
    Rev Clin Esp; 1983 Jul 15-31; 170(1-2):17-21. PubMed ID: 6635272
    [No Abstract]   [Full Text] [Related]  

  • 14. [Long-term therapy with oral prazosin in chronic congestive heart failure: a clinical and echocardiographic evaluation (author's transl)].
    Sparvieri F; Cesari GP; Soro A
    G Ital Cardiol; 1980; 10(6):730-40. PubMed ID: 6780400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improved exercise ejection fraction with long-term prazosin therapy in patients with heart failure.
    Goldman SA; Johnson LL; Escala E; Cannon PJ; Weiss MB
    Am J Med; 1980 Jan; 68(1):36-42. PubMed ID: 7350803
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vasodilatation with captopril and prazosin in chronic heart failure: double blind study at rest and on exercise.
    Bayliss J; Canepa-Anson R; Norell MS; Poole-Wilson P; Sutton G
    Br Heart J; 1986 Mar; 55(3):265-73. PubMed ID: 3513808
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of prazosin effect in severe chronic CHF.
    Ihlen H; Thaulow E; Kjekshus J; Forfang K
    Acta Med Scand Suppl; 1981; 652():149-54. PubMed ID: 6949461
    [No Abstract]   [Full Text] [Related]  

  • 18. Management of refractory CHF with prazosin: importance of tolerance and tachyphylaxis.
    Awan NA; Evenson MK; Needham KE; Mason DT
    Acta Med Scand Suppl; 1981; 652():115-24. PubMed ID: 6949458
    [No Abstract]   [Full Text] [Related]  

  • 19. Controlled study of long-term prazosin in refractory heart failure.
    Lemke R; Trompler A; Kaltenbach M; Bussmann WD
    Eur Heart J; 1981 Jun; 2(3):211-6. PubMed ID: 7274282
    [No Abstract]   [Full Text] [Related]  

  • 20. [Correlations between resting hemodynamics and exercise tolerance before and after prazosin therapy in patients with chronic congestive heart failure].
    Ogawa T; Sekiguchi T; Ishii M; Sugishita Y; Ito I
    Kokyu To Junkan; 1985 Feb; 33(2):171-7. PubMed ID: 4001595
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.